RxDoctor Payments Data

Dawn Begner, NP

Psychiatric/Mental Health · Tupelo, MSNPI 1053041251

Payments from drug & device makers

$3,207in general payments, 2019–2025

Across 170 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$351
  • AbbVie$257
  • Lundbeck LLC$256
  • Otsuka America Pharmaceutical, Inc.$160
  • Axsome Therapeutics, Inc.$139
  • plus $414 from 10 others

What the payments were for

  • Food & beverage$3,13398%
  • Education$732%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,207 in reported general payments places this provider in the 80th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$4,134
Medicare patients
20
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$177,829
Abilify MaintenaAripiprazole57$152,044
Invega SustennaPaliperidone Palmitate32$91,991
RexultiBrexpiprazole46$66,741
VraylarCariprazine Hcl14$19,272
TrintellixVortioxetine Hydrobromide14$9,068
Lurasidone Hcl11$5,810
Paliperidone ErPaliperidone16$2,865
Buspirone Hcl169$2,274
Oxcarbazepine63$1,468
Quetiapine Fumarate104$1,408
Fluphenazine Hcl20$1,323
Clozapine16$1,257
Hydroxyzine Pamoate87$1,195
Haloperidol Decanoate43$1,166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$160$218,785103 claims
Teva Pharmaceuticals USA, Inc.Austedo$18$177,82914 claims
Johnson & JohnsonInvega Sustenna$1,630$91,99132 claims
AbbVieVraylar$257$19,27214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →